Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Citigroup
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.2M | 5.7M | 1.28 |
| 2025-03-31 | $2.5M | 2.1M | 1.15 |
| 2024-09-30 | $4.7M | 4.0M | 1.17 |
| 2024-06-30 | $7.7M | 7.2M | 1.08 |
| 2024-03-31 | $2.4M | 2.6M | 0.94 |
| 2023-12-31 | $1.2M | 1.3M | 0.98 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1